VANCOUVER, British Columbia, Nov. 14, 2017 -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is pleased to announce it has entered into an agreement with Fort McMurray #468 First Nation to provide management and consultancy services relating to:
- Cannabis Licensing Application Development
- Geotechnical, Engineering and Architecture for a 24,000 square foot licensed Cannabis production facility
- Strategic planning pertaining to government relations in the Cannabis sector
“Our organization uniquely provides turnkey Cannabis industry solutions for Indigenous Peoples and other clients. Through our environmentally sustainable production model and end-to-end solutions, we intend to emerge as the trusted provider of choice for Indigenous Peoples’ Cannabis industry partnerships across Canada. This mutually beneficial agreement represents an important first step in this direction. We are extremely excited to enter into this unique partnership with Fort McMurray #468 First Nation,” said George Robinson, CEO of RavenQuest.
Fort McMurray #468 First Nation’s Chief, Ron Kreutzer, said of the agreement that, “The Fort McMurray #468 First Nation is very pleased to engage with an industry-leading partner as we embark into this burgeoning new industry. Given the positive and sustainable economic development this partnership means for our community, we recognize the importance of being early movers as the Cannabis industry continues its rapid expansion.”
About RavenQuest Biomed Inc.
RavenQuest Biomed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.
For further details on the Company readers are referred to the Company's web site (www.rqbglobal.com) and its Canadian regulatory filings on SEDAR at www.sedar.com.
On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.
"George Robinson"
Chief Executive Officer
For further information, please contact:
Mathieu McDonald, Corporate Communications
1-877-282-1586
Neither Canadian Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.
Cautionary Note Regarding Forward-Looking Statements
All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including statements with respect to the development of a licensed cannabis production facility and anticipated production from such a facility. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.


Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Amazon Explores AI Content Marketplace With Media Publishers
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 



